Generex Biotechnology Corp (GNBTQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
(Values in U.S. thousands)
| 07-2020 | 07-2019 | 07-2018 | 07-2017 | 07-2016 | |
| Sales | 2,661 | 6,204 | 703 | 0 | 0 |
| Cost of Goods | 580 | 4,139 | N/A | N/A | N/A |
| Gross Profit | 2,082 | 2,065 | 703 | N/A | N/A |
| Operating Expenses | 20,599 | 26,549 | 3,199 | 1,597 | 1,903 |
| Operating Income | -17,937 | -24,345 | -2,496 | -1,597 | -1,903 |
| Interest Expense | 7,104 | 7,088 | 584 | 743 | 419 |
| Other Income | -9,191 | 20,426 | 39,028 | -74,493 | -902 |
| Pre-tax Income | -34,232 | -11,007 | 35,949 | -76,833 | -3,223 |
| Net Income Continuous | -34,232 | -11,007 | 35,949 | -76,833 | -3,223 |
| Minority Interests | -897 | -1,665 | -385 | -6,816 | N/A |
| Net Income | $-33,335 | $-9,341 | $36,334 | $-70,016 | $-3,223 |
| EPS Basic Total Ops | -0.46 | -0.14 | 24.30 | -2.41 | -0.13 |
| EPS Basic Continuous Ops | -0.47 | -0.16 | 24.04 | -2.65 | -0.13 |
| EPS Diluted Total Ops | -0.46 | -0.14 | 10.01 | -2.41 | -0.13 |
| EPS Diluted Continuous Ops | -0.47 | -0.16 | 9.91 | -2.65 | -0.13 |
| EPS Diluted Before Non-Recurring Items | -0.34 | -0.07 | -0.99 | 0.18 | 0.00 |
| EBITDA(a) | $-8,279 | $-20,609 | $-2,472 | $11,789 | $-1,637 |